Promoting TERT promoter mutations for prognostication in cutaneous oncology

Affiliations

Editorial

Warren R Heymann. J Am Acad Dermatol. 2019 Mar.

. 2019 Mar;80(3):606-607.

doi: 10.1016/j.jaad.2018.12.039. Epub 2018 Dec 22.

¹ Division of Dermatology, Cooper Medical School of Rowan University, Marlton, New Jersey. Electronic address: wrheymann@gmail.com.

No abstract available

Comment on

TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA, Macedo S, Fernandes M, Pestana A, Pardal J, Batista R, Vinagre J, Sanches A, Baptista A, Lopes JM, Soares P. Campos MA, et al. J Am Acad Dermatol. 2019 Mar;80(3):660-669.e6. doi: 10.1016/j.jaad.2018.08.032. Epub 2018 Aug 28. J Am Acad Dermatol. 2019. PMID: 30165166
The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.
Walton KE, Garfield EM, Zhang B, Quan VL, Shi K, Mohan LS, Haugh AM, VandenBoom T, Yazdan P, Isales MC, Panah E, Gerami P. Walton KE, et al. J Am Acad Dermatol. 2019 Mar;80(3):685-693. doi: 10.1016/j.jaad.2018.09.030. Epub 2018 Oct 1. J Am Acad Dermatol. 2019. PMID: 30287318